Home › Funds › SAMLYN CAPITAL, LLC › RCUS

SAMLYN CAPITAL, LLC position in RCUS

ARCUS BIOSCIENCES INC · Health Care

SAMLYN CAPITAL, LLC reported holding 1,547,182 shares of RCUS (ARCUS BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$47.7M, representing 0.79% of its reported portfolio and ranking #39 among its reported holdings. SAMLYN CAPITAL, LLC has disclosed RCUS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.55M sh
Reported value held$47.70M
Portfolio Weight0.79%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SAMLYN CAPITAL, LLC's RCUS position evolved

SAMLYN CAPITAL, LLC first disclosed a stake in RCUS in Q4 2025 at 1,604,270 shares (US$38.2M). The position peaked in Q2 2026 at 1,547,182 shares, worth US$47.7M. Across 3 filings, SAMLYN CAPITAL, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,547,182 shares valued at US$47.7M — a reduction of -361,230 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 1.60M $38.23M New
Q1 2026 1.91M $41.22M Add
Q2 2026 1.55M $47.70M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RCUS and 13F data

RCUS (ARCUS BIOSCIENCES INC) is a Health Care company. 46 other funds we track also report a position in RCUS — the largest reported positions include GILEAD SCIENCES, INC. (US$968.8M), MONTANOVA CAPITAL, LLC (US$147.3M), Siren, L.L.C. (US$74.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RCUS

All RCUS fund holders →

FAQ

How long has SAMLYN CAPITAL, LLC held RCUS?

SAMLYN CAPITAL, LLC has disclosed RCUS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is SAMLYN CAPITAL, LLC's current position in RCUS?

As of Q2 2026, SAMLYN CAPITAL, LLC holds 1.55M shares of RCUS (ARCUS BIOSCIENCES INC), valued at $47.70M, representing 0.79% of its reported portfolio and ranking #39.

Has SAMLYN CAPITAL, LLC been buying or selling RCUS?

In the latest 13F filing (Q2 2026), SAMLYN CAPITAL, LLC reduced its position in RCUS. The position peaked in Q2 2026 at 1.55M shares.

Which other funds hold RCUS?

Other major institutional holders of RCUS include GILEAD SCIENCES, INC., MONTANOVA CAPITAL, LLC, Siren, L.L.C., among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.